Healthcare provider profile · identity verified

Jacob P Casey, MD

Internal Medicine · PORTLAND, OR · NPI 1942689930

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	597	170
Amlodipine Besylate	Amlodipine Besylate	435	130
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	280	55
Lisinopril	Lisinopril	270	85
Levothyroxine Sodium	Levothyroxine Sodium	259	69
Omeprazole	Omeprazole	201	64
Losartan Potassium	Losartan Potassium	191	59
Gabapentin	Gabapentin	169	55
Oxycodone Hcl	Oxycodone Hcl	146	34
Tamsulosin Hcl	Tamsulosin Hcl	140	41
Metoprolol Succinate	Metoprolol Succinate	137	37
Trazodone Hcl	Trazodone Hcl	123	37
Duloxetine Hcl	Duloxetine Hcl	117	25
Metformin Hcl	Metformin Hcl	117	38
Metformin Hcl Er	Metformin Hcl	102	33
Fluoxetine Hcl	Fluoxetine Hcl	90	32
Potassium Chloride	Potassium Chloride	89	33
Chlorthalidone	Chlorthalidone	87	27
Hydrochlorothiazide	Hydrochlorothiazide	87	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	28
Albuterol Sulfate Hfa	Albuterol Sulfate	83	33
Ozempic	Semaglutide	82	12
Eliquis	Apixaban	74	25
Fluticasone Propionate	Fluticasone Propionate	73	32
Simvastatin	Simvastatin	70	26
Furosemide	Furosemide	69	26
Mirtazapine	Mirtazapine	67	19
Pantoprazole Sodium	Pantoprazole Sodium	66	21
Montelukast Sodium	Montelukast Sodium	62	16
Alendronate Sodium	Alendronate Sodium	60	20
Allopurinol	Allopurinol	58	13
Metoprolol Tartrate	Metoprolol Tartrate	56	13
Sertraline Hcl	Sertraline Hcl	56	19
Spironolactone	Spironolactone	56	16
Venlafaxine Hcl Er	Venlafaxine Hcl	55	17
Clopidogrel	Clopidogrel Bisulfate	51	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	12
Glipizide Er	Glipizide	50	16
Jardiance	Empagliflozin	50	12
Bupropion Xl	Bupropion Hcl	49	18
Rosuvastatin Calcium	Rosuvastatin Calcium	48	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	11
Clonazepam	Clonazepam	46	suppressed
Pravastatin Sodium	Pravastatin Sodium	46	12
Alprazolam	Alprazolam	45	13
Diazepam	Diazepam	43	13
Morphine Sulfate Er	Morphine Sulfate	43	suppressed
Buspirone Hcl	Buspirone Hcl	41	14
Escitalopram Oxalate	Escitalopram Oxalate	41	12
Carvedilol	Carvedilol	39	11
Famotidine	Famotidine	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	12
Methylphenidate Er	Methylphenidate Hcl	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	11
Warfarin Sodium	Warfarin Sodium	34	11
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Atenolol	Atenolol	32	suppressed
Lorazepam	Lorazepam	32	14
Promethazine Hcl	Promethazine Hcl	32	suppressed
Risperidone	Risperidone	31	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Lovastatin	Lovastatin	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	29	suppressed
Myrbetriq	Mirabegron	27	suppressed
Prednisone	Prednisone	27	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Estradiol	Estradiol	26	suppressed
Finasteride	Finasteride	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Baclofen	Baclofen	24	suppressed
Pregabalin	Pregabalin	24	13
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	12
Glipizide	Glipizide	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Minoxidil	Minoxidil	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Lidocaine	Lidocaine	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Trulicity	Dulaglutide	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ondansetron Odt	Ondansetron	14	11
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Amantadine	Amantadine Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Prezcobix	Darunavir/Cobicistat	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Tivicay	Dolutegravir Sodium	12	suppressed
Colchicine	Colchicine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error